abrdn plc Has $987,000 Holdings in National Health Investors, Inc. (NYSE:NHI)

abrdn plc raised its holdings in National Health Investors, Inc. (NYSE:NHIFree Report) by 107.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,668 shares of the real estate investment trust’s stock after acquiring an additional 9,145 shares during the quarter. abrdn plc’s holdings in National Health Investors were worth $987,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Baystate Wealth Management LLC bought a new stake in National Health Investors in the fourth quarter worth $39,000. International Assets Investment Management LLC raised its stake in shares of National Health Investors by 3,690.7% in the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock valued at $1,588,000 after acquiring an additional 27,680 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in National Health Investors by 4.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock worth $10,568,000 after purchasing an additional 8,316 shares during the last quarter. Asset Management One Co. Ltd. boosted its position in National Health Investors by 14.6% during the fourth quarter. Asset Management One Co. Ltd. now owns 107,762 shares of the real estate investment trust’s stock worth $6,110,000 after purchasing an additional 13,692 shares during the period. Finally, Raymond James Financial Services Advisors Inc. grew its holdings in National Health Investors by 14.4% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock valued at $1,730,000 after purchasing an additional 3,907 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

Wall Street Analysts Forecast Growth

NHI has been the subject of several recent analyst reports. Truist Financial upped their price objective on shares of National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a report on Thursday, April 4th. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective for the company in a research report on Tuesday, March 12th. Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $55.00 to $63.00 in a report on Monday, February 26th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on National Health Investors in a report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price target for the company. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $60.50.

Get Our Latest Analysis on NHI

Insider Activity

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was purchased at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the transaction, the director now directly owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 7.26% of the stock is owned by company insiders.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $62.76 on Tuesday. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of 20.05 and a beta of 0.95. National Health Investors, Inc. has a one year low of $47.54 and a one year high of $63.42. The business has a fifty day simple moving average of $59.94 and a 200 day simple moving average of $55.86. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.74%. The ex-dividend date is Wednesday, March 27th. National Health Investors’s payout ratio is 115.02%.

National Health Investors Company Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Recommended Stories

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.